Sale!

Cultured AFB Antitubercular DST Moxifloxacin Test

910 د.إ

-10%

The “Cultured AFB Antitubercular DST Moxifloxacin Test” is a specialized diagnostic procedure aimed at assessing the susceptibility of Mycobacterium tuberculosis, the bacterium responsible for tuberculosis (TB), to the antibiotic Moxifloxacin. This test is particularly crucial for patients with TB to determine the most effective treatment regimen, especially in cases where resistance to standard first-line anti-TB drugs is suspected or confirmed.

The process involves culturing the patient’s sample to grow any Mycobacterium tuberculosis bacteria present. Once a culture is established, the DST (Drug Susceptibility Testing) is performed specifically for Moxifloxacin, a fluoroquinolone antibiotic that is used as a second-line treatment option for TB. The test results guide healthcare providers in tailoring the most appropriate and effective treatment plans for TB patients, especially those with multidrug-resistant TB (MDR-TB).

In the United Arab Emirates, this test is available at DNA Labs, a reputable laboratory known for its comprehensive range of diagnostic services. The cost of the “Cultured AFB Antitubercular DST Moxifloxacin Test” at DNA Labs UAE is 910 AED. This investment in accurate diagnostic testing is crucial for the effective management and treatment of tuberculosis, ensuring patients receive the most targeted therapy based on their specific infection profile.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

CULTURED AFB ANTITUBERCULAR DST MOXIFLOXACIN Test

Test Cost: AED 910.0

Symptoms, Diagnosis, and Test Details

The Cultured AFB Antitubercular DST Moxifloxacin test is a laboratory test used to determine the susceptibility of Mycobacterium tuberculosis (the bacteria that causes tuberculosis) to the antibiotic moxifloxacin. This test is part of the drug susceptibility testing (DST) process, which helps guide the selection of appropriate antibiotics for the treatment of tuberculosis.

During the test, a sample of the patient’s sputum or other body fluid is collected and cultured to isolate the tuberculosis bacteria. The isolated bacteria are then exposed to various concentrations of moxifloxacin in the laboratory. The growth of the bacteria is observed over a specific period of time to determine the minimum inhibitory concentration (MIC) of moxifloxacin that prevents bacterial growth.

The MIC value obtained from the test helps classify the tuberculosis bacteria as either susceptible, intermediate, or resistant to moxifloxacin. This information is crucial for healthcare providers to select the most effective antibiotics for the treatment of tuberculosis and prevent the development of drug resistance.

It is important to note that the Cultured AFB Antitubercular DST Moxifloxacin test is just one of the many tests performed as part of the overall DST process. Other antibiotics, such as isoniazid and rifampin, are also tested to determine their effectiveness against the tuberculosis bacteria. The results of these tests help guide the selection of a combination of antibiotics for the treatment of tuberculosis.

Test Components and Price

Components: Cultured AFB Antitubercular DST Moxifloxacin

Price: 910.0 AED

Sample Condition and Report Delivery

Sample Condition: Submit pure growth of Mycobacterium tuberculosis complex on appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigerated OR when used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submitted will be processed for Antitubercular Sensitivity.

Report Delivery: Sample daily by 3.30 pm; Report 21 days

Method and Test Type

Method: Automated Fluorescent

Test Type: Tuberculosis

Doctor and Test Department

Doctor: Physician

Test Department: DNA Labs UAE

Pre Test Information

No special preparation required

Test Name CULTURED AFB ANTITUBERCULAR DST MOXIFLOXACIN Test
Components
Price 910.0 AED
Sample Condition Submit pure growth ofMycobacterium tuberculosis complexon appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigerated ORwhen used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submittedwill be processed for Antitubercular Sensitivity.
Report Delivery Sample Daily by 3.30 pm; Report 21 days
Method Automated Fluorescent
Test type Tuberculosis
Doctor Physician
Test Department:
Pre Test Information No special preparation required
Test Details

The Cultured AFB Antitubercular DST Moxifloxacin test is a laboratory test used to determine the susceptibility of Mycobacterium tuberculosis (the bacteria that causes tuberculosis) to the antibiotic moxifloxacin. This test is part of the drug susceptibility testing (DST) process, which helps guide the selection of appropriate antibiotics for the treatment of tuberculosis.

During the test, a sample of the patient’s sputum or other body fluid is collected and cultured to isolate the tuberculosis bacteria. The isolated bacteria are then exposed to various concentrations of moxifloxacin in the laboratory. The growth of the bacteria is observed over a specific period of time to determine the minimum inhibitory concentration (MIC) of moxifloxacin that prevents bacterial growth.

The MIC value obtained from the test helps classify the tuberculosis bacteria as either susceptible, intermediate, or resistant to moxifloxacin. This information is crucial for healthcare providers to select the most effective antibiotics for the treatment of tuberculosis and prevent the development of drug resistance.

It is important to note that the Cultured AFB Antitubercular DST Moxifloxacin test is just one of the many tests performed as part of the overall DST process. Other antibiotics, such as isoniazid and rifampin, are also tested to determine their effectiveness against the tuberculosis bacteria. The results of these tests help guide the selection of a combination of antibiotics for the treatment of tuberculosis.